Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in 100-count Unit Dose Cartons ...
FDA Recall #D-0844-2020 — Class III — December 13, 2019
Product Description
Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in 100-count Unit Dose Cartons , Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 United States; Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6735-61
Reason for Recall
Failed Dissolution Specifications: High out of specification result observed at stability studies.
Recalling Firm
The Harvard Drug Group — Livonia, MI
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
246 Cartons
Distribution
U.S.A. Nationwide
Code Information
Lot# M02465D
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.